Standard

ISPE ISPE Good Practice Guide: Harmonizing the Definition and Use of Non-Investigational Medicinal Products (NIMPs)

Publisert
For bestilling og priser av dette produktet ta kontakt med salg@standard.no

Omfang

Recent survey results show that the pharmaceutical companies often take an overly conservative approach to NIMPs (or Non-IMPs) due to regulatory and operational ambiguity. This can lead to unnecessary expenses and process steps, which can needlessly complicate clinical trials. The ISPE Good Practice Guide: Harmonizing the Definition and Use of Non-Investigational Medicinal Products (NIMPs) aims to provide practical operational guidance and drive a consistent industry approach to the use of NIMPs. The Guide contains criteria for classifying NIMPs and an overview of current NIMP regulatory requirements. This in-depth Guide will help you properly manage NIMPs by providing guidance on: Sourcing strategies Packaging and labeling approaches Storage and distribution recommendations Regulations categorized by region/country Approaches to management of drug accountability, traceability, complaints and recalls with reference to the original sourcing strategy Regulatory differences between NIMPs and comparators

Dokumentinformasjon

  • Standard fra ISPE
  • Publisert:
  • Versjon: 0
  • Varetype: IS